1168133-91-2

Upstream product

• 1168133-89-8 2-(3-cyclopropylmethoxy-4-nitrophenyl)-4-methylpentanoic acid cyclopropylmethyl ester 
• 1168133-88-7 2-(3-fluoro-4-nitrophenyl)-4-methylpentanoic acid ethyl ester 
• 1168133-87-6 2-(3-fluoro-4-nitrophenyl)-4-methylpentanoic acid 
• 1168133-86-5 2-(3-fluoro-4-nitrophenyl)-2-isobutylmalonic acid diethyl ester 
• 446-35-5 2,4-Difluoronitrobenzene 
• 10203-58-4 (2-methylpropyl)-propanedioic acid, diethyl ester 
• 1168133-90-1 2-(4-amino-3-cyclopropylmethoxyphenyl)-4-methylpentanoic acid cyclopropylmethyl ester 

Downstream Products

• 1168133-92-3 2-(3-chloro-5-cyclopropylmethoxy-4-iodophenyl)-4-methylpentanoic acid cyclopropylmethyl ester 
• 1168132-01-1 2-(4-benzo[c][1,2,5]thiadiazol-5-yl-3-chloro-5-cyclopropylmethoxyphenyl)-4-methylpentanoic acid 
• 1168133-94-5 2-(4-benzo[c][1,2,5]thiadiazol-5-yl-3-chloro-5-cyclopropylmethoxyphenyl)-4-methylpentanoic acid cyclopropylmethyl ester 
• 1168131-65-4 2-(4-benzo[c][1,2,5]oxadiazol-5-yl-3-chloro-5-cyclopropylmethoxyphenyl)-4-methylpentanoic acid 
• 1168133-93-4 2-(4-benzo[c][1,2,5]oxadiazol-5-yl-3-chloro-5-cyclopropylmethoxyphenyl)-4-methylpentanoic acid cyclopropylmethyl ester 

Relevant academic research and scientific papers

TETRASUBSTITUTED BENZENES FOR TREATMENT OF EARLY ONSET ALZHEIMER'S DISEASE

Provided are compositions and methods for treating early onset familial Alzheimer's Disease. The compositions and methods can be used for improving one or more aspects of cognitive function in a patient suffering from early onset familial Alzheimer's Dise

TETRASUBSTITUTED BENZENES

Tetrasubstituted benzenes that act as modulators of gamma secretase and their use in the treatment of one or more symptoms of treating neurodegenerative disorders, e.g., Alzheimer's disease, are described.